MD-Syn is a user-friendly web portal for predicting drug synergy. It integrates a one-dimensional feature embedding module (1D-FEM), a two-dimensional feature embedding module (2D-FEM), and a deep neural network classifier to identify synergistic drug combinations. This interpretable framework prioritizes drug pairs by combining chemical structures and cancer cell line gene expression profiles, offering researchers actionable insights for combination therapy development.
Enter the name of your drug in the 'Drug1 Name' field. This can be any standard drug name (e.g., Doxorubicin).
Provide the SMILES notation of your drug in the 'Drug1 SMILES' field. SMILES is a chemical notation that represents the structure of your molecule.
Choose the appropriate cell line from the dropdown menu. This selection will determine the context of your drug synergy prediction.
Click the 'Predict Synergy' button to run the analysis. The tool will evaluate potential drug combinations and their synergistic effects.
Enter your email address and click 'Send Results' to receive a detailed report of the predictions.
Note: For best results, ensure that the SMILES notation is correct and properly formatted. You can find SMILES structures in chemical databases like PubChem or ChEMBL.